Cargando…

Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome)

In this paper we describe the function and phenotype of natural killer (NK) lymphocytes from HLA class I–deficient patients. These cells are, as has been previously reported, unable to lyse HLA class I(−) K562 cells, but are able to perform antibody-dependent cellular cytotoxicity (ADCC), although w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmer, Jacques, Donato, Lionel, Hanau, Daniel, Cazenave, Jean-Pierre, Tongio, Marie-Marthe, Moretta, Alessandro, de la Salle, Henri
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1998
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199183/
https://www.ncbi.nlm.nih.gov/pubmed/9419217
_version_ 1782148153858850816
author Zimmer, Jacques
Donato, Lionel
Hanau, Daniel
Cazenave, Jean-Pierre
Tongio, Marie-Marthe
Moretta, Alessandro
de la Salle, Henri
author_facet Zimmer, Jacques
Donato, Lionel
Hanau, Daniel
Cazenave, Jean-Pierre
Tongio, Marie-Marthe
Moretta, Alessandro
de la Salle, Henri
author_sort Zimmer, Jacques
collection PubMed
description In this paper we describe the function and phenotype of natural killer (NK) lymphocytes from HLA class I–deficient patients. These cells are, as has been previously reported, unable to lyse HLA class I(−) K562 cells, but are able to perform antibody-dependent cellular cytotoxicity (ADCC), although with lower efficiency as compared to NK cells from normal individuals. Transporter associated to antigen processing (TAP)(−) NK cells proliferate when cultured in the presence of lymphoblastoid B cells (B-LCs) and interleukin 2 and develop a spectrum of cytotoxicity similar to that of activated normal NK cells. Importantly, activation of the TAP(−) NK cells induces strong cytotoxicity to autologous B-LCs. Analysis of the phenotype of circulating TAP(−) NK lymphocytes showed them to display a normal diverse repertoire of HLA class I–specific NK receptors. These receptors were expressed at normal levels, apart from the CD94–NKG2A complex, which appeared to be overexpressed. This latter finding could reflect an adaptation to the low expression of HLA class I molecules. Finally, functional analyses indicated that the inhibitory receptors in TAP(−) individuals can transduce inhibitory signals. Our results suggest that in vivo, the NK cells of TAP(−) patients could participate in immune defense, at least through ADCC, but upon activation, may be involved in autoimmune processes.
format Text
id pubmed-2199183
institution National Center for Biotechnology Information
language English
publishDate 1998
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21991832008-04-16 Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome) Zimmer, Jacques Donato, Lionel Hanau, Daniel Cazenave, Jean-Pierre Tongio, Marie-Marthe Moretta, Alessandro de la Salle, Henri J Exp Med Brief Definitive Report In this paper we describe the function and phenotype of natural killer (NK) lymphocytes from HLA class I–deficient patients. These cells are, as has been previously reported, unable to lyse HLA class I(−) K562 cells, but are able to perform antibody-dependent cellular cytotoxicity (ADCC), although with lower efficiency as compared to NK cells from normal individuals. Transporter associated to antigen processing (TAP)(−) NK cells proliferate when cultured in the presence of lymphoblastoid B cells (B-LCs) and interleukin 2 and develop a spectrum of cytotoxicity similar to that of activated normal NK cells. Importantly, activation of the TAP(−) NK cells induces strong cytotoxicity to autologous B-LCs. Analysis of the phenotype of circulating TAP(−) NK lymphocytes showed them to display a normal diverse repertoire of HLA class I–specific NK receptors. These receptors were expressed at normal levels, apart from the CD94–NKG2A complex, which appeared to be overexpressed. This latter finding could reflect an adaptation to the low expression of HLA class I molecules. Finally, functional analyses indicated that the inhibitory receptors in TAP(−) individuals can transduce inhibitory signals. Our results suggest that in vivo, the NK cells of TAP(−) patients could participate in immune defense, at least through ADCC, but upon activation, may be involved in autoimmune processes. The Rockefeller University Press 1998-01-05 /pmc/articles/PMC2199183/ /pubmed/9419217 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Brief Definitive Report
Zimmer, Jacques
Donato, Lionel
Hanau, Daniel
Cazenave, Jean-Pierre
Tongio, Marie-Marthe
Moretta, Alessandro
de la Salle, Henri
Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome)
title Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome)
title_full Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome)
title_fullStr Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome)
title_full_unstemmed Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome)
title_short Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome)
title_sort activity and phenotype of natural killer cells in peptide transporter (tap)-deficient patients (type i bare lymphocyte syndrome)
topic Brief Definitive Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199183/
https://www.ncbi.nlm.nih.gov/pubmed/9419217
work_keys_str_mv AT zimmerjacques activityandphenotypeofnaturalkillercellsinpeptidetransportertapdeficientpatientstypeibarelymphocytesyndrome
AT donatolionel activityandphenotypeofnaturalkillercellsinpeptidetransportertapdeficientpatientstypeibarelymphocytesyndrome
AT hanaudaniel activityandphenotypeofnaturalkillercellsinpeptidetransportertapdeficientpatientstypeibarelymphocytesyndrome
AT cazenavejeanpierre activityandphenotypeofnaturalkillercellsinpeptidetransportertapdeficientpatientstypeibarelymphocytesyndrome
AT tongiomariemarthe activityandphenotypeofnaturalkillercellsinpeptidetransportertapdeficientpatientstypeibarelymphocytesyndrome
AT morettaalessandro activityandphenotypeofnaturalkillercellsinpeptidetransportertapdeficientpatientstypeibarelymphocytesyndrome
AT delasallehenri activityandphenotypeofnaturalkillercellsinpeptidetransportertapdeficientpatientstypeibarelymphocytesyndrome